Presentation EuroPCR 2018

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Presenter: Andreas Baumbach

May 25, 2018

REGISTER for free or LOG IN to view this content

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Coronary

DES/BRS/DCB

Presentation

EuroPCR 2018

TARGET AC

Up Next

Presentation Intravascular Coronary Imaging and Physiology 2018

The Value of Intravascular Imaging for Left Main and Complex Bifurcation PCI

Presenter: Michael S. Lee

May 06, 2018

More slides +

Presentation Intravascular Coronary Imaging and Physiology 2018

Use of Adjunctive Technology in CTO and Complex Cases–How IntravscularImaging Saved the Day

Presenter: Dimitri Karmpaliotis

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Stent Failures -Identifying Causes of Stent Thrombosis and Restenosis and How to Fix It

Presenter: Ron Waksman

May 05, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.